Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Taysha Gene Therapies (TSHA) Interest & Investment Income: 2020-2024

Historic Interest & Investment Income for Taysha Gene Therapies (TSHA) over the last 5 years, with Dec 2024 value amounting to $6.9 million.

  • Taysha Gene Therapies' Interest & Investment Income rose 50.40% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 12.47%. This contributed to the annual value of $6.9 million for FY2024, which is 94.29% up from last year.
  • Taysha Gene Therapies' Interest & Investment Income amounted to $6.9 million in FY2024, which was up 94.29% from $3.6 million recorded in FY2023.
  • Over the past 5 years, Taysha Gene Therapies' Interest & Investment Income peaked at $6.9 million during FY2024, and registered a low of $49,000 during FY2020.
  • In the last 3 years, Taysha Gene Therapies' Interest & Investment Income had a median value of $3.6 million in 2023 and averaged $3.6 million.
  • Data for Taysha Gene Therapies' Interest & Investment Income shows a peak YoY spiked of 1,334.54% (in 2023) over the last 5 years.
  • Taysha Gene Therapies' Interest & Investment Income (Yearly) stood at $49,000 in 2020, then surged by 251.02% to $172,000 in 2021, then soared by 44.77% to $249,000 in 2022, then soared by 1,334.54% to $3.6 million in 2023, then surged by 94.29% to $6.9 million in 2024.